Correlation of peripheral blood eosinophil counts with atherosclerotic cardiovascular disease: a cross-sectional

Runze Chang1, Chuanlong Lu1, Ruijing Zhang2

  • 1Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Wuyi Road No. 382, Taiyuan, 030001, Shanxi, People's Republic of China.

Scientific Reports
|November 14, 2025
PubMed

Insights

Higher eosinophil counts are linked to increased risk of atherosclerotic cardiovascular diseases (ASCVD) in US adults. This association is stronger in older individuals, smokers, and males, highlighting specific populations for targeted prevention.

Area of Science:

  • Immunology
  • Cardiology
  • Epidemiology

Background:

  • Inflammation is central to Atherosclerotic Cardiovascular Diseases (ASCVD).
  • The role of eosinophils, innate immune cells, in cardiovascular disease is debated, with conflicting evidence.
  • Understanding eosinophil's specific impact on ASCVD is crucial for risk stratification.

Purpose of the Study:

  • To investigate the association between eosinophil count and ASCVD in a US adult population.
  • To identify specific demographic subgroups with a potentially stronger link between eosinophil levels and ASCVD.
  • To provide insights into the inflammatory mechanisms underlying ASCVD.

Main Methods:

  • Cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES) data (2011-2018).
  • Eosinophil counts determined from laboratory results; ASCVD diagnosed via self-report of specific conditions.
  • Multivariate logistic regression models used to assess the association, adjusting for covariates.

Main Results:

  • A significant positive association was observed between higher eosinophil counts and ASCVD.
  • Subgroup analyses indicated this association was more pronounced in older adults, male participants, and smokers.
  • The findings suggest eosinophils may serve as a potential biomarker for ASCVD risk.

Conclusions:

  • Elevated eosinophil counts are positively correlated with ASCVD in the US adult population.
  • The link between eosinophils and ASCVD is particularly strong in older individuals, males, and smokers.
  • Further research may elucidate the precise mechanisms and clinical utility of eosinophil counts in ASCVD prediction.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
376